Amgen (AMGN) is a publicly traded Healthcare sector company. As of May 31, 2026, AMGN trades at $336.71 with a market cap of $181.77B and a P/E ratio of 23.25. AMGN moved +0.09% today. Year to date, AMGN is +2.79%; over the trailing twelve months it is +18.78%. Its 52-week range spans $253.30 to $391.29. Analyst consensus is buy with an average price target of $364.70. Rallies surfaces AMGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for AMGN, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $336.71 |
| Market Cap | $181.77B |
| P/E Ratio | 23.25 |
| EPS | $14.48 |
| Dividend Yield | 2.52% |
| 52-Week High | $391.29 |
| 52-Week Low | $253.30 |
| Volume | 1.31M |
| Avg Volume | 0 |
| Revenue (TTM) | $37.22B |
| Net Income | $7.80B |
| Gross Margin | 68.26% |
24 analysts cover AMGN: 0 strong buy, 10 buy, 13 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $364.70.